| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. | Lancet | 1998 | 4.05 |
| 2 | Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. | JAMA | 1995 | 2.63 |
| 3 | Reversal of severe serous atrophy of the bone marrow in anorexia nervosa. | JPEN J Parenter Enteral Nutr | 1987 | 0.80 |
| 4 | IL-1ra administration does not improve cardiac function in patients with severe sepsis. | J Crit Care | 1999 | 0.76 |